Working with interdisciplinary teams and nurse navigators to coordinate care across specialties is a facet of oncology nursing that may be overlooked, says an expert.

Experts discuss how to balance treatment intensity with maintaining quality of life, particularly in patients with advanced-stage disease.

Experts discuss effective communication strategies for managing patient and caregiver expectations about treatment adverse ...

Patricia Jakel, MN, RN, AOCN, emphasized that the bond oncology nurses have with patients with cancer necessitates honest and ...

A recent study found that toxicity is routinely minimized in phase 3 oncology trials, especially those that are not industry sponsored.

What multidisciplinary strategies have you found effective in managing the range of side effects associated with ALK inhibitors?

In your experience, how does lorlatinib’s side effect profile compare to other ALK inhibitors? Are there unique challenges or benefits with lorlatinib?

And again, it's very important that we educate the population. And when nurses are educated on the different subtypes of breast cancer, then we can also—we feel empowered. And now we can empower the ...

Panitumumab plus ipilimumab and nivolumab signaled complete or partial response in 18 patients with KRAS/NRAS/BRAF wild-type MSS mCRC at the 12-week mark. The addition of ipilimumab (Yervoy) and ...

Although participants in the study had greater rates of nonadherence postintervention, those who reported nonadherence at ...